The Net Margin of CareDx, Inc. (CDNA) is
-5.62%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date |
Value |
| 2025-12-31 |
-5.62%
|
| 2024-12-31 |
15.74%
|
| 2023-12-31 |
-67.88%
|
| 2022-12-31 |
-23.80%
|
| 2021-12-31 |
-10.36%
|
| 2020-12-31 |
-9.73%
|
| 2019-12-31 |
-17.31%
|
| 2018-12-31 |
-61.10%
|
| 2017-12-31 |
-114.91%
|
| 2016-12-31 |
-97.29%
|
| Ticker |
Name |
Value |
|
EDIT
|
Editas Medicine, Inc.
|
-395.01%
|
|
FGEN
|
FibroGen Inc
|
-160.63%
|
|
LGND
|
Ligand Pharmaceuticals Incorporated
|
46.42%
|
|
VCYT
|
Veracyte, Inc.
|
12.83%
|
|
SWTX
|
SpringWorks Therapeutics, Inc.
|
-134.73%
|
|
AGIO
|
Agios Pharmaceuticals, Inc.
|
-764.01%
|
|
ARNA
|
Arena Pharmaceuticals Inc
|
-1141542.60%
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
31.41%
|
|
RVMD
|
Revolution Medicines, Inc.
|
-3768.28%
|
|
GBT
|
Global Blood Therapeutics Inc
|
-155.63%
|
|
MRNA
|
Moderna, Inc.
|
-145.16%
|
|
OPGN
|
CapForce Inc
|
230.80%
|
|
VIE
|
Viela Bio Inc
|
-1293.07%
|
|
950160.KQ
|
Kolon TissueGene Inc
|
-3733.25%
|
|
BHVN
|
Biohaven Ltd.
|
-1205.09%
|
|
CCXI
|
Churchill Capital Corp XI
|
-408.87%
|
|
FOLD
|
Amicus Therapeutics Inc
|
-4.27%
|
|
GILD
|
Gilead Sciences, Inc.
|
28.90%
|
|
SRNE
|
Sorrento Therapeutics Inc
|
-912.10%
|
|
AMGN
|
Amgen Inc
|
20.98%
|
|
ORGO
|
Organogenesis Holdings Inc.
|
6.56%
|
|
RLAY
|
Relay Therapeutics, Inc.
|
-1800.58%
|
|
ABBV
|
AbbVie Inc.
|
6.91%
|
|
APLS
|
Apellis Pharmaceuticals, Inc.
|
2.23%
|
|
IGMS
|
IGM Biosciences LLC
|
-7316.16%
|
|
PTCT
|
PTC Therapeutics, Inc.
|
39.44%
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
32.94%
|
|
950200.KQ
|
Psomagen Inc
|
-5.04%
|
|
GNLKQ
|
Genelink Inc
|
-142.86%
|
|
GTH
|
Genetron Holdings Ltd
|
-124.24%
|
|
LEGN
|
Legend Biotech Corporation
|
-28.85%
|
|
950220.KQ
|
Neoimmunetech Inc
|
-33533.01%
|
|
ALXO
|
ALX Oncology Holdings Inc
|
-3876.27%
|
|
INSM
|
Insmed Incorporated
|
-210.54%
|
|
VCEL
|
Vericel Corporation
|
5.98%
|